Toca Stock Forecast 2023, 2024, 2025, 2030

by Cavix   ·  January 14, 2023   ·  

Tocagen Inc is a clinical-stage cancer-selective gene therapy firm that aimed at developing and popularizing product candidates that engage a patient’s immune system against cancer. Its cancer-specific gene therapy technology is based on retroviral replicating vectors (RRVs), which are meant to introduce therapeutic genes into cancer cells’ DNA. Toca 511 & Toca FC, Toca stock principal product ...